(Q34786314)

4 August 2017

title

Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population (English)

1 reference

inflammatory bowel diseases

4 August 2017

main subject

0 references

Clostridium difficile

0 references

author

Christopher John Lindsell

4

object named as

Christopher J Lindsell

1 reference

4 August 2017

Ethan Mezoff

1

1 reference

4 August 2017

Elizabeth A Mann

2

1 reference

4 August 2017

Kim Ward Hart

3

1 reference

4 August 2017

Mitchell B Cohen

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Journal of Pediatric Gastroenterology and Nutrition

4 August 2017

published in

1 reference

4 August 2017

volume

52

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

437-441

1 reference

Treatment with monoclonal antibodies against Clostridium difficile toxins

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

Clostridium difficile--more difficult than ever

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

Update on the changing epidemiology of Clostridium difficile-associated disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

Incidence of Clostridium difficile infection in inflammatory bowel disease.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075442

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis

26 October 2018

1 reference

12 December 2020

Impact of Clostridium difficile on inflammatory bowel disease

1 reference

12 December 2020

Changing epidemiology of Clostridium difficile-associated disease in children

1 reference

12 December 2020

The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission

1 reference

12 December 2020

Impact of Clostridium difficile Infection on Pediatric Inflammatory Bowel Disease

1 reference

12 December 2020

10.1097/MPG.0B013E3181F97209

Identifiers

DOI

1 reference

4 August 2017

1 reference

4 August 2017

1 reference